Total raised
$2.5M
Last: Seed 2016-03
Stage
Acquired
Founded
2015
Headcount
1-10
HQ
Ramat HaSharon
Sector
Health Tech & Life Sciences
About
RondinX is building a target and drug discovery platform designed to create solutions in the microbiome therapeutic and companion diagnostic spaces. RondinX's core technology is a peak-to-trough family of algorithms exclusively licensed from YEDA, the commercial arm of the Weizmann Institute of Science. The proprietary, cloud-based computational pipeline uses raw metagenomics to derive both static and dynamic strain-level insights into the bacterial ecosystem.
Funding history · 1 round · $2.5M total
2016-03
Seed
$2.5M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is RondinX's primary focus?
- RondinX is building a target and drug discovery platform designed to create solutions in the microbiome therapeutic and companion diagnostic spaces.
- When was RondinX founded?
- RondinX was founded in May 2015.
- What is the status of RondinX as of December 2017?
- RondinX was acquired by BiomX in December 2017 and is currently inactive.
- What is the core technology of RondinX?
- RondinX's core technology is a peak-to-trough family of algorithms exclusively licensed from YEDA, the commercial arm of the Weizmann Institute of Science.
- How much funding did RondinX raise in total?
- RondinX raised a total of $2,500,000 in funding. For a full financing history, please refer to startupim.
- Which investors participated in RondinX's Seed round?
- RondinX's Seed round in March 2016 included investors such as Elevator Fund and 8VC.
- What was a key development for RondinX in January 2017?
- In January 2017, RondinX expanded its microbiome computational platform for drug development with a unified reference range of bacterial dynamics, based on a database of 1,400 healthy individuals.
- Who are the founders of RondinX?
- The founders of RondinX are Guy Harmelin, Rafi Gidron, and Alon Hirsch.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMicroorganisms
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
microbiologygenomicsbiotechnologybioinformaticsbacteriamicrobiomenovel-ingredientsprecision-medicinepharma-companies